CTRI/2021/08/035823尚未招募未知
Optimization of Dosage Regimen of Amikacin: A Pharmacometric Approach
Manipal Center for infectious Diseases0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Patients diagnosed with sepsis: Infection site suspected, microbiological sampling done, and prescribed with Amikacin as part of therapeutic management.
- •Patients whose age is > 18 and < 60
排除标准
- •Pregnant or lactating women
- •Patients who are not willing to give informed consent
- •Blood transfusion >4 units per week
- •Patients on dialysis
- •Patients with chronic kidney disease
- •Inability to get consent of the patient or next of kin
- •Second admission to ICU or previous enrolment in study (within same hospital admission)
研究者
相似试验
尚未招募
不适用
Pharmacokinetic study of Amikacin in NeonatesCTRI/2019/10/021750Manipal academy of higher education
已完成
不适用
Personalized Dose Optimization of Amikacin Guided by Pharmacokinetic Modeling Software in Patients With Septic ShockShock, SepticNCT04178148Centre Hospitalier Universitaire de Nīmes180
进行中（未招募）
不适用
Amikacine nébulisée à forte dose. Pharmacocinétique dans la pneumonie associée à la ventilation mécaniqueD’ARTAGNAN 3 - Dartagnan3Ventilator associated pneumoniaMedDRA version: 9.1Level: LLTClassification code 10065153Term: Ventilator associated pneumoniaEUCTR2008-000248-15-FRAssociation pour la promotion de la réanimation médicale à Tours24
已完成
不适用
Once daily dose of Amikacin versus twice daily dose for treatment of early onset neonatal sepsiseonatal sepsis.P36.8IRCT201112248507N1Mazandaran University of Medical Sciences32
Unknown
不适用
Amikacin Pharmacokinetics to Optimize Dosing Recommendations in Neonates With Perinatal Asphyxia Treated With HypothermiaAsphyxia NeonatorumNCT04867993University of Sarajevo80